XmAb-2513
Product Specifications
Target
TNF
Related Pathways
Apoptosis
Bioactivity
XmAb-2513 is a humanized monoclonal antibody inhibitor targeting CD30. It demonstrates significant anti-proliferative activity along with excellent antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) . XmAb-2513 is applicable in research on hematological malignancies such as Hodgkin lymphoma (HL) and anaplastic large cell lymphoma (ALCL) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6124532-01 0.1 mL
TAG-72 (CA 72.4, Tumor Associated GlycoProtein 72) (HRP)
Sign In for Pricing
View Details MBS6124532-02 5x 0.1 mL
TAG-72 (CA 72.4, Tumor Associated GlycoProtein 72) (HRP)
Sign In for Pricing
View Details 
MBS6424355-01 0.1 mL
KvLQT1 (Potassium Voltage-gated Channel Subfamily KQT Member 1, KCNQ1, ATFB1, ATFB3, JLNS1, KCNA8, KCNA9, Kv1.9, Kv7.1, LQT, LQT1, RWS, SQT2, WRS) (HRP)
Sign In for Pricing
View Details MBS6424355-02 5x 0.1 mL
KvLQT1 (Potassium Voltage-gated Channel Subfamily KQT Member 1, KCNQ1, ATFB1, ATFB3, JLNS1, KCNA8, KCNA9, Kv1.9, Kv7.1, LQT, LQT1, RWS, SQT2, WRS) (HRP)
Sign In for Pricing
View Details 
S1014-61K 50 µg
SMARCD2 (SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator Of Chromatin Subfamily D Member 2, 60kD BRG-1/Brm-Associated Factor Subunit B, BRG1-Associated Factor 60B, BAF60B, PRO2451) discontinued
Sign In for Pricing
View Details